ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Plasmapheresis"

  • 2017 American Transplant Congress

    Prognostic Tools to Choose Candidates for Successful Desensitization.

    D. Pinelli,1 A. Zachary,2 J. Friedewald,1 M. Leffell,2 D. Lucas,2 R. Montgomery,2 A. Tambur.1

    1Northwestern University, Chicago, IL; 2Johns Hopkins, Baltimore, MD

    Antibodies to donor HLA antigens are a barrier to solid organ transplantation. Strategies to desensitize patients have improved, but the ability to predict response to…
  • 2017 American Transplant Congress

    Successful Launch of an ABO-Incompatible Kidney Transplantation Program to Overcome the Shortage of Compatible Living Donors: Experience at a Single Center.

    S. Song,1 J. Lee,1 J. Lee,1 S.-K. Kwon,1 B. Kim,2,3 J. Lee,1 Y. Kim,1,3 M. Kim,1,3 S. Kim,1,3 K. Huh.1,3

    1Transplantation Surgery, Yonsei University Health System, Seoul, Republic of Korea; 2Nephrology, Yonsei University Health System, Seoul, Republic of Korea; 3The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea

    Introduction:ABO-incompatible (ABOi) kidney transplantation (KT) is being increasingly performed to overcome donor shortages. However, debate persists regarding the post-transplant outcomes of ABOi KT versus that…
  • 2017 American Transplant Congress

    Outcome of ABO-Incompatible Kidney Transplantation After Stratified Desensitization.

    K. Nanmoku, A. Kurosawa, T. Kubo, T. Shinzato, T. Shimizu, T. Kimura, T. Yagisawa.

    Surgical Branch, Institute of Kidney Diseases, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan

    Background. Plasmapheresis for antibody removal and rituximab for antibody production suppression are performed for desensitization against ABO-incompatible kidney transplantation. We evaluated clinical outcome for optimizing…
  • 2017 American Transplant Congress

    The Inhibitory Effect of Plasma on T Cell Activation: Possible Role of Plasma Exchange in Anti Rejection Therapy.

    A. Assounga,1,2 S. Omarjee.1

    1Dept Nephrology, University of KwaZulu-Natal, Durban, South Africa; 2Inkosi Albert Luthuli Central Hospital, Durban, South Africa

    Reduction of lymphocyte proliferation by human plasma has been previously reported. Reduced activation of lymphocytes of patients on immunosuppressive drugs is well documented.Aim: To compare…
  • 2016 American Transplant Congress

    Analysis of FSGS (Focal Segmental Glomerulosclerosis) Recurrence After Renal Transplantation.

    J. Mansur, G. Basso, M. Cristelli, G. Mata, T. Sandes-Freitas, G. Kirsztajn, H. Tedesco-Silva, J. Medina-Pestana.

    Nephrology-Division, Hospital do Rim - UNIFESP, São Paulo, Brazil.

    Purpose: To describe clinical-laboratorial profile and outcome of patients diagnosed with recurrent FSGS submitted to plasmapheresis.Methods: Retrospective single-center cohort study including all patients with recurrent…
  • 2016 American Transplant Congress

    Insights into the Treatment of Post-Transplant Focal Glomerulosclerosis: Experience Gained from a Concise Diagnostic and Management Protocol.

    K. Koutroutsos,1 R. Charif,1 L. Moran,2 J. Moss,2 T. Cook,2 C. Roufosse,2 D. Taube,1 M. Loucaidou.1

    1Kidney and Transplant Centre, Imperial Healthcare NHS Trust, London, United Kingdom; 2Department of Histopathology, Imperial Healthcare NHS Trust, London, United Kingdom.

    Background: Recurrence of Focal Glomerulosclerosis (FSGS) after kidney transplantation is associated with poor graft survival. We present results from a concise diagnostic and management protocol…
  • 2016 American Transplant Congress

    Utilization of Plasmapheresis and High Dose of Immunoglobulins in the Treatment of the High Level of De Novo Donor Specific Antibodies for the Successful Islet Allotransplantation.

    J. Solomina,1 Z. Tekin,1 S. Matosz,1 K. Golab,1 C. Thomas,2 J. Golebiewska,3 S. Ramachandran,1 L. Schenck,1 W. Chon,1 M. Tibudan,1 N. Marek-Trzonkowska,4 J. Millis,1 P. Witkowski.1

    1Surgery, University of Chicago, Chicago, IL; 2Medicine, University of Chicago, Chicago, IL; 3Internal Medicine, Medical University of Gdansk, Gdansk, Poland; 4Family Medicine, Medical University of Gdansk, Gdansk, Poland.

    Background.Development of donor specific antibodies (DSA) after islet transplantation has been a poor prognostic factor for graft survival, while no intervention is implemented. Here, we…
  • 2016 American Transplant Congress

    A2 Kidneys into B Recipients: Is Postoperative Anti-A1 Titer Monitoring Useful?

    A. DeMers, R. Forbes, D. Moore, K. Smith, D. Shaffer.

    Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, TN.

    Background: Since the introduction of the new Kidney Allocation System in December 2014, our center implemented a protocol for transplanting A2 kidneys into B recipients…
  • 2016 American Transplant Congress

    Early Posttransplant Complications Following Abo-Incompatible Kidney Transplantation.

    L. Rostaing,1,2,3 A. Allal,1 H. Naciri Benami,1 Z. Abdulrahman,1 L. Esposito,1 F. Sallusto,1 N. Doumerc,1 X. Game,1 B. Debiol,1 N. Congy,1 N. Kamar.1,3,4

    1Néphrologie et Transplantation d'Organes, CHU Rangueil, Toulouse, France; 2INSERM U 563, CHU Purpan, Toulouse, France; 3Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier, Toulouse, France; 4INSERM U1043 CNRS UMR 5282, CHU Purpan, Toulouse, France.

    Introduction: Many studies or registries particularly in Japan, but also in Western Europe, have shown that long-term results from ABO-incompatible (ABOi) living-kidney transplantation are as…
  • 2016 American Transplant Congress

    Postoperative Rebound of Anti-Blood Type Antibodies and Antibody-Mediated Rejection After ABO-Incompatible Living Related Kidney Transplantation – Is Prophylactic Treatment Necessary?

    H. Ishida, T. Kondo, T. Shimizu, T. Nozaki, K. Tanabe.

    Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan.

    PURPOSE: The role of postoperative anti-ABO titers in acute rejection under our current immunosuppressive regimen remains unclear. Some institutions recommend postoperative therapeutic plasma exchange to…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences